EMC (NYSE:EMC): Pacific Crest recommends buying shares on any weakness, as it expects growth to reaccelerate in the second half of 2013. The firm expects the company to report lower-than-expected second-quarter revenue.
Health Management (NYSE:HMA): Credit Suisse has taken its rating on Health Management to Neutral from Outperform, saying that the valuation reflects a fair takeout range. It has a price target of $16 on the share.
Zumiez (NASDAQ:ZUMZ): RW Baird remains undeterred with its Zumiez thesis despite June comps that are coming in slightly below consensus. The firm notes that weekly comps have improved during the month, and it expects July to show improvement based on easier comparisons. It keeps an Outperform rating on the shares with a $37 price target.
Thor Industries (NYSE:THO): RW Baird believes that Thor Industries is well-positioned to capitalize on the cyclical recovery and expects opportunities for margin improvement as fundamentals improve. The firm would look to add positions on any weakness and although maintaining its Neutral rating, raised its price target to $56 from $48.